• Content Type

Strategies and roadmaps

Impact of AI on the regulation of medical products

Overview

This document summarises the MHRA’s strategic approach to AI regulation following the UK Government request for an update from regulators on how they are taking forward the White Paper proposals.

This content is available under the Open Government Licence v3.0.

External Links

Access document

Key Information

Jurisdiction: UK - UK-wide

Name of organisation: Medicines and Healthcare products Regulatory Agency

Date published: 30 Apr 2024

License: Crown Copyright 2022

Categorisation

Domain: Healthcare and medicine - Medical devices
Topic: Adoption and commercialisation, Good practice in development and use
Type: Strategies and roadmaps
Share on XShare on LinkedIn

Discussion forum

  • Author
    Posts
  • 15 January 2025 at 3:20 pm
    Up
    0
    ::
    JOJohn

    Share your thoughts on this item here.

  • Author
    Posts

You must be logged in to contribute to the discussion

Login